No Data
No Data
Xintai Healthcare (02291) will pay a final dividend of $0.57 per share on September 30
Xintai Healthcare (02291) announced that the company will pay a final dividend per share on September 30, 2024...
心泰醫療:2023年度股東週年大會通告
心泰醫療:2023年度報告
LEPU ScienTech Medical Adopts New Standard for Financial Reporting; Replaces Auditor
LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) will adopt the China Accounting Standards for Business Enterprises (CASBE) to prepare its financial statements beginning from the interim report
Xintai Medical (02291.HK) plans to appoint Lixin as a new auditor
Xintai Healthcare (02291.HK) issued an announcement. In view of the proposed adoption of Chinese accounting standards, in order to implement effective cost control and reduce overall operating expenses to better match the Group's future business development, on April 7, 2024, the company invited qualified accounting firms including PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) to tender for audit services for the year ended December 31, 2024. According to the audit tender results, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) was not selected. The Company Audit Committee was received from PricewaterhouseCoopers
Xintai Healthcare (02291.HK) plans to use Chinese corporate accounting standards to prepare financial statements and disclose relevant financial information
Xintai Healthcare (02291.HK) issued an announcement. In order to improve work efficiency and reduce the audit costs of preparing two financial statements in accordance with Chinese accounting standards and international financial reporting standards, on April 7, 2024, the board of directors reviewed and approved the preparation of the company's financial statements and disclosure of relevant financial information in accordance with Chinese corporate accounting standards starting from the interim report for the six months ending June 30, 2024, subject to approval by the company's shareholders at the recent annual shareholders' meeting to be held on May 23, 2024 to revise the company's articles of association.
No Data